Valley Medical Pharmacy 
630 Main Street 
Brawley, CA 92227 
eRx ID#0585957 
1 (800) 322-0808 | Toll Free Fax: 1 (855) 322-0808 
Email: drugsdepot@yahoo.com 
Web: www.drugsdepot 
Timing: Monday to Friday | 9:00 AM to 5:45 PM 


Low-Ogestrel 0.3-0.03mg Tabs 6x28 By Actavis Pharma

Image 0 of Low-Ogestrel 0.3-0.03mg Tabs 6x28 By Actavis Pharma Image 1 of Low-Ogestrel 0.3-0.03mg Tabs 6x28 By Actavis Pharma

Low-Ogestrel 0.3-0.03mg Tabs 6x28 By Actavis Pharma

Call for Price

Low-Ogestrel 0.3-0.03mg Tabs 6x28 By Actavis Pharma This Item Requires A Valid Order From A Physician Licensed in USA. Item Number.:RXB10043044/RXD2910602/RXA314774/RXI1766716
Size : 6X28
Selling UoM : EA
NDC: 52544-0847-28
UPC Barcode : 352544847284
Supplier: 0050000679 ACTAVIS PHARMA INC/GENERIC
Supplier Material : 084728
Generic Code : 003310 NORGESTREL-ETHINYL ESTRADIOL ORAL TABLET
Fine Line Class : 850085008510 All Rx Products
Product Category : RX Pharmaceuticals

Have a question?

  Call for Price

Product Description.:

WATSON, 847 or P1
tablet , multi-colored , round round
21 white (847), 7 peach (P1)

Low-Ogestrel ? Tablets (norgestrel and ethinyl estradiol tablets USP, 0.3 mg/0.03 mg) provide an oral contraceptive regimen consisting of 21 white tablets followed by 7 peach tablets.

Each white tablet, for oral administration contains 0.3 mg of norgestrel and 0.03 mg ethinyl estradiol and the following inactive ingredients: croscarmellose sodium, lactose, magnesium stearate, microcrystalline cellulose, and povidone.

Each inactive peach tablet, for oral administration, in the 28 day regimen contains the following inactive ingredients: anhydrous lactose, FD&C Yellow No. 6 Lake, lactose monohydrate, magnesium stearate, and microcrystalline cellulose.

INDICATIONS AND USAGE

Low-Ogestrel? (norgestrel and ethinyl estradiol tablets USP, 0.3 mg/0.03 mg) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.

CONTRAINDICATIONS

Oral contraceptives should not be used in women who have the following conditions:

*

Thrombophlebitis or thromboembolic disorders
*

A past history of deep vein thrombophlebitis or thromboembolic disorders
*

Cerebral vascular or coronary artery disease
*

Known or suspected carcinoma of the breast
*

Carcinoma of the endometrium or other known or suspected estrogen-dependent neoplasia
*

Undiagnosed abnormal genital bleeding
*

Cholestatic jaundice of pregnancy or jaundice with prior pill use
*

Hepatic adenomas, carcinomas or benign liver tumors
*

Known or suspected pregnancy